Mediclin (MED.DE) Stock Price

Currency:

Mediclin Price

🇩🇪XETRA·CLOSED

3.68EUR

Market closed

Today +/-

+0.02 EUR

Today %

+0.54 %

Mediclin (MED.DE) — ISIN DE0006595101. The Mediclin stock price was 3.68 EUR in 2026. Revenue was 809.62 M EUR. Earnings were 35.5 M EUR. P/E ratio was 4.92. Mediclin operates in the Health sector.

Mediclin stock price

Ex-Dividend

Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Mediclin over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Mediclin stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Mediclin's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Mediclin Stock Price History

Date	Mediclin Price
3/11/2026	3.68 EUR
3/10/2026	3.66 EUR
3/9/2026	3.56 EUR
3/6/2026	3.70 EUR
3/5/2026	3.66 EUR
2/26/2026	3.88 EUR
2/25/2026	3.86 EUR
2/24/2026	3.88 EUR
2/23/2026	3.84 EUR
2/20/2026	3.80 EUR
2/19/2026	3.78 EUR
2/18/2026	3.82 EUR
2/17/2026	3.72 EUR
2/16/2026	3.70 EUR
2/13/2026	3.52 EUR
2/12/2026	3.88 EUR
2/11/2026	3.88 EUR
2/10/2026	3.88 EUR

API Docs Get API Key

Mediclin Revenue, EBIT, Net Income

3 Years
5 Years
10 Years
25 Years
Max

Unlock the full history with 30+ years of data and forecast estimates.

Unlock all data — PRO

Revenue

EBIT

Net Income

Details

API Docs Get API Key

Mediclin Income Statement, Balance Sheet, Cash Flow Statement

Last updated Mar 12, 2026, 11:12 AM

REVENUE (M EUR)

REVENUE GROWTH (%)

GROSS MARGIN (%)

GROSS INCOME (M EUR)

NET INCOME (M EUR)

NET INCOME GROWTH (%)

SHARES (M)

DOCUMENTS

1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025e	2026e	2027e
288	317	329	387	375	372	377	387	398	466	480	497	505	517	521	544	562	589	626	654	686	670	687	722	766	765	790	809	825
–	10.07	3.79	17.63	-3.10	-0.80	1.34	2.65	2.84	17.09	3.00	3.54	1.61	2.38	0.77	4.41	3.31	4.80	6.28	4.47	4.89	-2.33	2.54	5.09	6.09	-0.13	3.27	2.41	1.98
80.21	81.70	79.94	80.10	80.00	80.38	79.84	79.33	78.64	77.25	77.50	77.87	78.22	78.53	78.69	80.51	81.67	81.49	81.95	81.80	82.36	83.28	82.10	81.58	82.11	83.14	80.51	78.62	77.09
231	259	263	310	300	299	301	307	313	360	372	387	395	406	410	438	459	480	513	535	565	558	564	589	629	636	636	636	636
-8	5	8	-13	-16	-13	7	9	5	7	10	10	3	-1	-2	8	16	16	3	7	9	-8	1	9	-10	24	35	35	35
–	-162.50	60.00	-262.50	23.08	-18.75	-153.85	28.57	-44.44	40.00	42.86	–	-70.00	-133.33	100.00	-500.00	100.00	–	-81.25	133.33	28.57	-188.89	-112.50	800.00	-211.11	-340.00	45.83	–	–
21.2	31.8	31.8	31.8	31.8	31.8	30.3	31.9	31.8	32.7	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5
–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–

Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Mediclin generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Mediclin retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Mediclin's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Mediclin has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Mediclin's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

ASSETS

CASH BALANCE (M EUR)

RECEIVABLES (M EUR)

OTHER RECEIVABLES (M EUR)OTHER REC. (M EUR)

INVENTORIES (M EUR)

OTHER CURRENT ASSETS (M EUR)OTHER CURRENT LIAB. (M EUR)

CURRENT ASSETS (M EUR)

TANGIBLE ASSETS (M EUR)

LONG-TERM INVESTMENTS (M EUR)LONG-T. INVEST. (M EUR)

LONG-TERM RECEIVABLES (k EUR)LONG-T. REC. (k EUR)

INTANGIBLE ASSETS (M EUR)INTANGIBLE ASSETS (M EUR)

GOODWILL (M EUR)

OTHER NON-CURRENT ASSETS (M EUR)OTHER NON-CURRENT ASSETS (M EUR)

NON-CURRENT ASSETS (M EUR)

TOTAL ASSETS (M EUR)

LIABILITIES

COMMON STOCK (M EUR)

ADDITIONAL PAID-IN CAPITAL (M EUR)

RETAINED EARNINGS (M EUR)

OTHER EQUITY (k EUR)OTHER EQUITY (k EUR)

UNREALIZED GAINS/LOSSES (M EUR)UNREAL. GAINS/LOSSES (M EUR)

EQUITY (M EUR)

LIABILITIES (M EUR)

PROVISIONS (M EUR)

OTHER SHORT-TERM LIABILITIES (M EUR)OTHER SHORT-TERM LIAB. (M EUR)

SHORT-TERM DEBTS (k EUR)SHORT-TERM DEBTS (k EUR)

SHORT-TERM PORTION OF LONG-TERM DEBTS (M EUR)LONG-TERM DEBT PORTION (M EUR)

SHORT-TERM RECEIVABLES (M EUR)SHORT-TERM REC. (M EUR)

LONG-TERM LIABILITIES (M EUR)LONG-T. LIAB. (M EUR)

DEFERRED TAXES (M EUR)

OTHER LIABILITIES (M EUR)OTHER LIAB. (M EUR)

LONG-TERM LIABILITIES (M EUR)LONG-T. LIABILITIES (M EUR)

DEBT (M EUR)

TOTAL CAPITAL (M EUR)

1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024

76	106.3	92.6	46.8	28.4	18.2	27	29.1	21.4	62.4	61.7	52	46.8	27	17	29.36	32.72	45.65	32.44	38.65	46.6	105.62	147.97	136.26	174.38	172.7
36.1	38.9	47	47.9	37.2	39.3	49.2	46.7	52.7	54	56.3	61.6	58.1	59.8	61.4	61.97	67.33	71.14	84	93.1	101.14	76.34	81.21	88.49	81.58	99.57
26.5	1.3	2.5	1.9	27.9	27.7	2.6	4.3	3	10.1	2.1	3.9	3	2.1	2.6	3.43	4.85	3.44	3.79	8.11	8.83	11.25	16.33	13.31	12.71	14.85
10	12.2	7.7	10.3	11.1	12	4.5	4.7	4.6	5.8	6.5	6.5	6.8	7.1	6.5	6.36	6.15	6.27	7.29	7.46	8.08	9.34	8.51	8.87	7.3	7.66
4.4	3.2	7.1	7.1	5.7	6.2	3.2	4.6	7.3	2.3	2	1.5	1.6	1.3	4.2	1.71	0.93	1.24	1.34	1.21	1.34	1.31	11.9	15.08	23.86	2.8
153	161.9	156.9	114	110.3	103.4	86.5	89.4	89	134.6	128.6	125.5	116.3	97.3	91.7	102.83	111.98	127.73	128.87	148.53	166	203.86	265.93	262.01	299.83	297.59
148.6	148.6	160.5	217.2	210.5	203.6	121.3	120.6	128.5	145.6	146.8	150.3	154.6	161.6	158.6	155.54	161.16	161.61	177.51	194.56	617.49	572.04	508.26	543.94	514.38	533.3
15.9	16	0.7	0.7	0.7	0	0.3	0.3	0.3	0.4	0.1	0.1	0.1	2.3	2.3	1.77	0.77	0.07	0.07	0.07	0.11	0.09	0.07	0.07	0.07	0.06
0	0	0	0	0	0	0	600	600	500	500	400	300	300	200	0	70.8	0.1	0	0	0	0	0	0	0	0
0.9	0.9	1.1	1.6	1.5	1.5	0.8	1.1	1.1	2	2.1	2.4	1.9	1.7	2.1	1.96	1.91	3.6	6.08	7.81	8.82	8.79	7.07	5.67	6.12	8.32
50.5	47.9	61	60.5	55.4	51.3	46.8	45	45.2	52.8	49.1	51.2	50.1	49.3	49.3	48.59	48.48	48.57	48.83	48.83	49.25	49.25	49.87	49.87	16.69	16.4
1	0.2	0.7	0.7	0.7	1.5	12.9	11.4	5.3	7.4	6.6	6.5	5.5	7.1	8.5	4.76	5.04	5.47	7.28	44.95	56.08	53.43	50.04	54.56	43.43	50.25
216.9	213.6	224	280.7	268.8	257.9	182.1	179	181	208.7	205.2	210.9	212.5	222.3	221	212.61	217.44	219.33	239.76	296.21	731.75	683.61	615.31	654.1	580.68	608.32
369.9	375.5	380.9	394.7	379.1	361.3	268.6	268.4	270	343.3	333.8	336.4	328.8	319.6	312.7	315.43	329.43	347.06	368.63	444.73	897.75	887.46	881.24	916.11	880.5	905.91

20.5	31.5	31.5	31.5	31.5	31.5	31.5	31.5	31.5	47.3	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	129.39	129.39	129.39
-10.6	95	103.8	82.9	62.9	49.3	55.8	66.9	72.7	101.6	109.8	117.4	118.1	109.6	104.9	106.84	121.99	134.39	138.03	144.11	143.49	129.66	135.78	32.32	19.03	45.61
0	0	0	0	0	-3,700	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-207	164	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
9.9	126.5	135.3	114.4	94.4	77.1	87.3	98.4	104.2	148.9	157.3	164.9	165.6	157.1	152.4	154.34	169.49	181.89	185.53	191.61	190.99	177.16	183.07	209.37	195.92	222.51
7	9.7	8.3	10.3	9.2	10.5	11	12.4	11.9	14.6	14.8	15.2	14.6	20.5	21.1	13.04	12.02	12.99	13.72	17.1	17.6	11.31	13.02	14.5	12.63	12.78
0	0	0	0	0	0	0	0	0	13.5	12.9	12.9	13.5	14.3	14.1	0	0	0	0	0	0	0	26.63	28.75	0	0
45.5	32.8	38.2	40.2	63.2	45.5	49.3	35.8	31.6	20.9	19.7	20.1	8.7	6.8	9	33.42	37.57	35.57	34.75	50.01	57.41	79.25	118.61	106.17	107.65	124.77
0	0	0	0	0	0	0	0	0	500	500	400	300	0	0	0	0	0	0	0	0	0	0	0	0	0
203	27.3	37.1	23.4	42	2.2	0.7	7.2	68.4	74.5	71.2	71.2	71.5	8.6	6.9	6.88	6.85	10.57	16.49	20.85	70.78	80.79	81.78	50.18	50.96	28.46
255.5	69.8	83.6	73.9	114.4	58.2	61	55.4	111.9	124	119.1	119.8	108.6	50.2	51.1	53.34	56.44	59.13	64.96	87.97	145.8	171.35	240.04	199.59	171.24	166.01
15	90	64.8	81.9	50.7	84.4	91.3	83.2	22.6	21.4	11.4	6.8	9.6	67	60.5	53.33	46.75	45.03	37.45	54.93	441.36	406.07	358.18	452.49	428.86	435.67
0	0	0	0	0	0	1.4	1.2	1.1	1.4	1.8	2.4	2.8	3.3	3.8	0	0	0	0	0	0	0	0	0	0	0
89.5	89.4	96.4	120.4	114.5	136.3	28.8	28.3	28.4	47.6	44.2	42.4	42.1	42.2	45.2	54.96	57.1	61.34	80.96	110.43	119.85	133.2	126.62	83.46	84.37	81.49
104.5	179.4	161.2	202.3	165.2	220.7	121.5	112.7	52.1	70.4	57.4	51.6	54.5	112.5	109.5	108.29	103.85	106.37	118.41	165.36	561.21	539.27	484.81	535.95	513.23	517.16
360	249.2	244.8	276.2	279.6	278.9	182.5	168.1	164	194.4	176.5	171.4	163.1	162.7	160.6	161.63	160.29	165.5	183.37	253.33	707.01	710.62	724.85	735.54	684.47	683.17
369.9	375.7	380.1	390.6	374	356	269.8	266.5	268.2	343.3	333.8	336.3	328.7	319.8	313	315.97	329.78	347.39	368.9	444.94	898	887.78	907.92	944.91	880.39	905.67

Details

Balance Sheet

ⓘ

What Is the Balance Sheet?

The balance sheet is a financial snapshot of Mediclin at a specific point in time. It follows the fundamental equation: Assets = Liabilities + Shareholders' Equity. Unlike the income statement (which covers a period), the balance sheet tells you what the company owns, what it owes, and what belongs to shareholders at a given date.

Assets

Current assets (cash, receivables, inventory) can be converted to cash within 12 months and indicate short-term liquidity. Non-current assets (property, equipment, intangible assets, goodwill) represent long-term investments. A high proportion of cash and short-term investments gives Mediclin financial flexibility to weather downturns, fund acquisitions, or return capital to shareholders.

Liabilities

Current liabilities (accounts payable, short-term debt) are obligations due within one year. Non-current liabilities (long-term debt, pension obligations) are due further out. Key ratio to watch: the debt-to-equity ratio (Total Debt ÷ Shareholders' Equity). A ratio below 1.0 is generally healthy, meaning the company is funded more by equity than debt. Highly leveraged companies amplify both gains and losses.

Shareholders' Equity

Equity is the residual value belonging to shareholders after all debts are paid. It includes retained earnings (accumulated profits not paid out as dividends) and paid-in capital. Rising equity year over year is a positive sign — it means Mediclin is building book value. Declining equity, especially when driven by losses or heavy share buybacks funded by debt, warrants closer scrutiny.

Key Ratios to Derive

From the balance sheet, you can calculate the current ratio (current assets ÷ current liabilities; above 1.5 is comfortable), book value per share (equity ÷ shares outstanding), and return on equity (net income ÷ equity; above 15 % is strong). Tracking these ratios over time reveals whether Mediclin is strengthening or weakening its financial position.

NET INCOME (M EUR)

DEPRECIATION AND AMORTIZATION M EURDEPRECIATION (M EUR)

DEFERRED TAXES (M EUR)

CHANGES IN WORKING CAPITAL (M EUR)CHANGES IN WORKING CAPITAL (M EUR)

NON-CASH ITEM (M EUR)

PAID INTEREST (M EUR)

PAID TAXES (M EUR)

Net Cash Flow from Operating Activities (M EUR)NET CASH FLOW FROM OPERATING ACTIVITIES (M EUR)

CAPITAL EXPENDITURES (M EUR)

CASH FLOW FROM INVESTING ACTIVITIES (M EUR)CASH FLOW FROM INVESTING ACTIVITIES (M EUR)

CASH FLOW FROM OTHER INVESTING ACTIVITIES (M EUR)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M EUR)

INTEREST INCOME AND EXPENSES (M EUR)

NET DEBT CHANGE (M EUR)NET DEBT CHANGE (M EUR)

Net change in equity (M EUR)NET CHANGE IN EQUITY (M EUR)

CASH FLOW FROM FINANCING ACTIVITIES (M EUR)CASH FLOW FROM FINANCING ACTIVITIES (M EUR)

OTHER ITEMS OF FINANCING CASH FLOWS (M EUR)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M EUR)

TOTAL DIVIDENDS PAID (M EUR)

NET CHANGE IN CASH FLOW (M EUR)

FREE CASH FLOW (M EUR)

SHARE-BASED COMPENSATION (M EUR)

1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
9	15	8	-13	-16	-13	16	16	18	15	16	16	10	4	2	15	23	24	3	7	9	-9	1	9	-10	24
25	15	15	21	21	22	7	8	8	12	14	13	16	17	17	18	18	19	20	22	71	77	73	71	86	50
0	0	0	0	0	0	0	0	5	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0
-55	15	-1	13	8	-20	12	-11	-10	4	5	-12	-1	0	-6	1	-6	-8	-16	-11	-18	42	3	-48	-18	-16
0	-12	7	-8	-5	21	-18	-5	-12	-8	-4	-5	-12	-5	-2	-3	-4	-4	12	9	7	7	3	2	20	21
0	0	0	0	0	0	0	0	0	0	5	5	4	2	2	0	1	1	1	2	9	8	8	10	21	22
0	0	0	0	0	0	0	0	0	0	1	2	1	0	1	0	0	4	5	4	3	0	2	3	-2	3
-19	34	29	13	6	11	17	7	11	24	32	13	15	16	9	32	30	29	20	27	69	118	81	34	78	80
0	0	0	0	0	0	0	0	-28	-19	-19	-21	-27	-24	-16	-19	-25	-26	-35	-46	-44	-25	-17	-26	-37	-44
380	-13	-23	-38	-12	-12	-14	-8	-19	-2	-15	-16	-22	-20	-11	-12	-18	-17	-37	-38	-35	-8	-7	-6	-9	-15
380	-13	-23	-38	-12	-12	-14	-8	9	17	3	5	5	4	5	7	6	8	-1	8	9	17	9	19	28	29
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-335	-100	-15	-16	-12	-6	0	0	0	-22	-13	-5	-5	-14	-8	-6	-7	1	-1	21	-18	-37	-46	-46	-23	-50
0	115	0	0	0	0	0	4	0	38	0	0	7	0	0	0	0	0	0	0	0	0	0	0	0	0
-337	8	-13	-21	-15	-6	5	2	0	14	-15	-7	0	-14	-8	-6	-8	0	2	17	-30	-46	-55	-56	-45	-73
-2	-5	1	-4	-3	0	5	-1	0	-1	0	0	0	0	0	0	-1	-1	4	-2	-9	-8	-8	-10	-21	-22
0	0	0	0	0	0	0	0	0	0	-2	-2	-2	0	0	0	0	0	0	-2	-2	0	0	0	0	0
23	30	-7	-46	-20	-7	8	2	-7	36	1	-10	-6	-18	-9	13	3	12	-14	6	3	63	19	-27	23	-7
-19.39	34.57	29.88	13.76	6.94	11	17.53	7.53	-17.26	4.88	13.27	-7.95	-11.89	-8.58	-6.68	12.15	4.98	3.75	-15.67	-18.47	24.66	92.52	64.96	8.62	40.43	35.88
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

API Docs Get API Key

Mediclin Stock Quarterly Figures

REVENUE (M EUR)

REVENUE GROWTH (%)

GROSS MARGIN (%)

GROSS INCOME (M EUR)

NET INCOME (M EUR)

NET INCOME GROWTH (%)

SHARES (M)

2000 Q1	2000 Q2	2000 Q3	2000 Q4	2001 Q1	2001 Q2	2001 Q3	2001 Q4	2002 Q1	2002 Q2	2002 Q3	2002 Q4	2003 Q1	2003 Q2	2003 Q3	2003 Q4	2004 Q1	2004 Q2	2004 Q3	2004 Q4	2005 Q1	2005 Q2	2005 Q3	2005 Q4	2006 Q1	2006 Q2	2006 Q3	2006 Q4	2007 Q1	2007 Q2	2007 Q3	2007 Q4	2008 Q1	2008 Q2	2008 Q3	2008 Q4	2009 Q1	2009 Q2	2009 Q3	2009 Q4	2010 Q1	2010 Q2	2010 Q3	2010 Q4	2011 Q1	2011 Q2	2011 Q3	2011 Q4	2012 Q1	2012 Q2	2012 Q3	2012 Q4	2013 Q1	2013 Q2	2013 Q3	2013 Q4	2014 Q1	2014 Q2	2014 Q3	2014 Q4	2015 Q1	2015 Q2	2015 Q3	2015 Q4	2016 Q1	2016 Q2	2016 Q3	2016 Q4	2017 Q1	2017 Q2	2017 Q3	2017 Q4	2018 Q1	2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3
72	81	81	82	77	80	83	89	91	102	99	93	91	96	96	91	87	90	93	94	89	95	96	96	93	96	96	101	96	98	101	101	110	118	117	119	114	121	121	122	120	125	123	128	123	126	126	129	127	130	131	128	127	135	132	127	134	135	137	137	138	139	141	142	143	149	147	148	149	155	161	159	159	165	165	164	169	170	171	174	169	158	177	164	159	169	177	180	176	184	174	186	181	195	192	197	191	187	194	191	192	203	210
–	12.50	–	1.23	-6.10	3.90	3.75	7.23	2.25	12.09	-2.94	-6.06	-2.15	5.49	–	-5.21	-4.40	3.45	3.33	1.08	-5.32	6.74	1.05	–	-3.13	3.23	–	5.21	-4.95	2.08	3.06	–	8.91	7.27	-0.85	1.71	-4.20	6.14	–	0.83	-1.64	4.17	-1.60	4.07	-3.91	2.44	–	2.38	-1.55	2.36	0.77	-2.29	-0.78	6.30	-2.22	-3.79	5.51	0.75	1.48	–	0.73	0.72	1.44	0.71	0.70	4.20	-1.34	0.68	0.68	4.03	3.87	-1.24	–	3.77	–	-0.61	3.05	0.59	0.59	1.75	-2.87	-6.51	12.03	-7.34	-3.05	6.29	4.73	1.69	-2.22	4.55	-5.43	6.90	-2.69	7.73	-1.54	2.60	-3.05	-2.09	3.74	-1.55	0.52	5.73	3.45
81.94	80.25	81.48	81.71	79.22	81.25	81.93	75.28	78.02	80.39	81.82	79.57	79.12	79.17	81.25	79.12	79.31	80.00	80.65	78.72	78.65	80.00	80.21	80.21	78.49	80.21	79.17	78.22	78.13	79.59	79.21	78.22	77.27	77.12	77.78	76.47	76.32	77.69	77.69	77.87	77.50	78.40	78.05	77.34	78.05	78.57	77.78	78.29	77.95	78.46	78.63	78.13	77.17	78.52	79.55	78.74	79.10	80.74	81.75	80.29	81.16	82.01	81.56	81.69	81.82	81.88	81.63	81.08	81.88	82.58	81.99	81.76	82.39	82.42	83.03	78.66	82.84	81.76	81.87	83.33	82.84	83.54	83.05	83.54	82.39	82.25	83.05	81.11	80.68	82.61	80.46	81.72	80.11	82.56	82.29	83.25	81.68	83.42	84.54	82.72	82.81	84.73	84.76
59	65	66	67	61	65	68	67	71	82	81	74	72	76	78	72	69	72	75	74	70	76	77	77	73	77	76	79	75	78	80	79	85	91	91	91	87	94	94	95	93	98	96	99	96	99	98	101	99	102	103	100	98	106	105	100	106	109	112	110	112	114	115	116	117	122	120	120	122	128	132	130	131	136	137	129	140	139	140	145	140	132	147	137	131	139	147	146	142	152	140	152	145	161	158	164	156	156	164	158	159	172	178
1	3	3	-2	2	2	5	0	-3	0	1	-11	-5	-4	0	-6	-4	-2	1	-10	-3	1	5	3	0	2	4	2	0	2	0	3	-1	2	4	1	-1	3	5	2	-1	3	4	3	-2	0	2	-5	-2	1	3	-7	-6	0	4	-1	-1	2	7	0	0	3	8	4	0	5	6	4	0	4	11	-11	0	3	7	-3	0	1	5	3	-5	-5	6	-4	-11	-3	10	6	-3	6	2	5	-6	11	10	-26	-1	1	14	9	0	9	15
–	200.00	–	-166.67	-200.00	–	150.00	–	–	–	–	-1,200.00	-54.55	-20.00	–	–	-33.33	-50.00	-150.00	-1,100.00	-70.00	-133.33	400.00	-40.00	–	–	100.00	-50.00	–	–	–	–	-133.33	-300.00	100.00	-75.00	-200.00	-400.00	66.67	-60.00	-150.00	-400.00	33.33	-25.00	-166.67	–	–	-350.00	-60.00	-150.00	200.00	-333.33	-14.29	–	–	-125.00	–	-300.00	250.00	–	–	–	166.67	-50.00	–	–	20.00	-33.33	–	–	175.00	-200.00	–	–	133.33	-142.86	–	–	400.00	-40.00	-266.67	–	-220.00	-166.67	175.00	-72.73	-433.33	-40.00	-150.00	-300.00	-66.67	150.00	-220.00	-283.33	-9.09	-360.00	-96.15	-200.00	1,300.00	-35.71	–	–	66.67
31.8	31.8	31.8	31.8	31.8	31.8	31.8	31.8	31.8	31.8	31.8	31.8	31.8	32.2	31.8	31.8	31.8	31.8	31.8	31.8	31.8	31.8	31.8	26.4	31.8	31.8	31.8	32.3	31.8	31.8	31.8	32.8	31.8	31.8	31.8	35.3	47.3	47.3	46.1	49.4	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	49.1	47.5	47.5	47.5	46.7	47.5	47.5	47.5	47.1	48.5	47.5	47.5	48.3	46.1	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5	47.5

Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Gross Margin

EBIT and EBIT Margin

Net Income and Earnings Per Share (EPS)

Shares Outstanding

Analyst Estimates

API Docs Get API Key

Mediclin stock margins

The Mediclin margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Mediclin. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Mediclin.

3 Years
5 Years
10 Years
25 Years
Max

Gross margin

EBIT margin

Profit margin

Details

API Docs Get API Key

Mediclin Stock Sales Revenue, EBIT, Earnings per Share

The Mediclin earnings per share therefore indicates how much revenue Mediclin has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

3 Years
5 Years
10 Years
25 Years
Max

Sales per Share

EBIT per share

Earnings per Share

Details

API Docs Get API Key

Mediclin business model

Mediclin AG is a German company specializing in the care and treatment of patients. It was founded in 1984 in Berlin and has since relocated its headquarters to Offenburg. Mediclin operates over 50 healthcare facilities throughout Germany, including hospitals, rehabilitation centers, nursing facilities, and medical care centers. The company employs approximately 10,000 employees and generated a revenue of 1.17 billion euros in 2020.

API Docs Get API Key

Mediclin SWOT Analysis

Strengths

Mediclin AG has a strong reputation in the healthcare industry due to its high-quality medical services and state-of-the-art facilities.

The company has a large network of hospitals and clinics, allowing it to serve a wide range of patients and offer diverse medical specialties.

Weaknesses

One weakness of Mediclin AG is its dependency on government contracts and reimbursements, which can be subject to changes in healthcare policies and regulations.

The company may face challenges in maintaining consistent revenue growth as healthcare costs continue to rise and potential budget constraints arise.

Opportunities

There is a growing demand for healthcare services, particularly in specialized areas such as geriatrics and mental health, which presents opportunities for Mediclin AG to expand its offerings.

The company can also explore partnerships and collaborations with research institutions or technology companies to enhance its medical technologies and treatments.

Threats

Increased competition within the healthcare industry poses a threat to Mediclin AG's market share and profitability.

Changes in healthcare regulations and policies, as well as potential economic downturns, can also pose threats to the company's financial stability.

API Docs Get API Key

Mediclin Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

API Docs Get API Key

Mediclin historical P/E ratio, EBIT multiple, and P/S ratio

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Mediclin's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Mediclin's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Mediclin's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Mediclin grows earnings faster than its peers.

API Docs Get API Key

Mediclin annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

API Docs Get API Key

Mediclin shares outstanding

The number of shares was Mediclin in 2025 — This indicates how many shares 47.5 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

3 Years
5 Years
10 Years
25 Years
Max

Number of stocks

Details

API Docs Get API Key

Mediclin Dividend History

8 years of dividend payments

YearAnnual DividendYoY ChangePayments

20250.04EUR↓ 20.0%1×

Jun 5, 20250.04EUR↓ 20.0%1/1

20190.05EUR 0.0%1×

20180.05EUR 0.0%1×

20110.05EUR 0.0%1×

20100.05EUR 0.0%1×

20090.05EUR↓ 50.0%1×

20030.1EUR↓ 33.3%1×

20020.15EUR—1×

API Docs Get API Key

Mediclin dividend history and estimates

In 2025, Mediclin paid a dividend amounting to 0.04 EUR. Dividend means that Mediclin distributes a portion of its profits to its owners.

3 Years
5 Years
10 Years
25 Years
Max

Dividend

Dividend (Estimate)

Details

API Docs Get API Key

Mediclin dividend payout ratio

In 2025, Mediclin had a payout ratio of 27.08%. The payout ratio indicates the percentage of the company's profits that Mediclin distributes as dividends.

3 Years
5 Years
10 Years
25 Years
Max

Payout ratio

Details

API Docs Get API Key

Current Mediclin forecasts and price targets in March 2026

Δ MOM Price Target	null %
Buy	80.00 % (4)
Hold	20.00 % (1)
Sell	null % (0)
12M Price Target	5.87
Last Price	3.16
Currency	EUR
12M Return Potential	85.60 %
LTM Return	0 %

API Docs Get API Key

EESG©

Eulerpool ESG Scorecard© for the Mediclin stock

46/100

Environment

Social

Governance

Environment

Scope 1 - Direct Emissions16,387.37

Scope 2 - Indirect emissions from purchased energy6,550.62

Scope 3 - Indirect emissions within the value chain98,652.38

Total CO₂ emissions22,937.99

CO₂ reduction strategy

Coal energy

Nuclear power

Animal experiments

Fur & Leather—

Pesticides—

Palm Oil—

Tobacco

Genetically modified organisms

Climate concept—

Sustainable forestry—

Recycling regulations

Environmentally friendly packaging

Hazardous substances

Fuel consumption and efficiency

Water consumption and efficiency

Social

Percentage of female employees42.3

Percentage of women in management—

Percentage of Asian employees—

Share of Asian management—

Percentage of Hispanic/Latino employees—

Hispano/Latino Management share—

Percentage of Black employees—

Black Management Share—

Percentage of white employees—

White Management Share—

Adult content

Alcohol

Weapons—

Firearms

Gambling

Military contracts

Human rights concept

Privacy concept—

Occupational health and safety

Catholic

Governance (Corporate Governance)

Environmental reporting

Stakeholder Engagement

Call Back Policies

Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

API Docs Get API Key

Mediclin shareholders

%	Name	Stocks	Change	Date
52.73000%	Asklepios Kliniken Verwaltungsgesellschaft mbH	25,046,750		6/24/2025
35.00000%	ERGO Versicherungsgruppe AG	16,625,000		6/24/2025
0.81650%	DFA Australia Ltd.	387,839	-14,699	4/30/2025
0.64132%	Knoesel & Ronge Vermögensverwaltung GmbH & Co. KG	304,628		3/31/2025
0.08249%	Dimensional Fund Advisors, L.P.	39,182	-491	5/31/2025
0.00372%	Mercer Global Investments Management Ltd	1,768		4/30/2025
%	VM Vermögens-Management GmbH		-100,000	11/30/2023
%	TBF Global Asset Management GmbH		-212,000	6/30/2024
%	Capio Capital GmbH		-100,000	12/31/2023

API Docs Get API Key

Mediclin Executives and Management Board

Mr. Hans Hilpert

(59)

Vice Chairman of the Supervisory Board, Employee Representative · since 2002

Compensation17,250EUR

Compensation17,250 EUR

Dipl. Kfm. Michael Bock

(62)

Independent Member of the Supervisory Board

14,250EUR

Compensation14,250 EUR

Mr. Matthias Werner

(51)

Member of the Supervisory Board, Employee Representative

12,743EUR

Compensation12,743 EUR

Ms. Walburga Erichsmeier

(63)

Member of the Supervisory Board, Employee Representative · since 2012

12,264EUR

Compensation12,264 EUR

Dr. Jan Liersch

(52)

Chairman of the Supervisory Board · since 2019

API Docs Get API Key

Mediclin Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite

1 companies

#	Name	1M	3M	6M	1Y	2Y	Trend
1	Muenchener Rueckversicher Supplier	0,37	-0,20	-0,07	-0,23	0,09

API Docs Get API Key

Mediclin Research

Soon

Deep-dive analyses, investment theses, and proprietary research — curated by Eulerpool.

Research reports are coming soon

We're building institutional-grade equity research for Mediclin and thousands of other companies.

Most common questions regarding Mediclin

The business model of Mediclin AG, a leading healthcare provider, revolves around offering a diverse range of medical services and high-quality patient care. With a focus on providing acute care, rehabilitation, and post-acute care, Mediclin AG operates a network of clinics and hospitals across Germany. Its services include specialized medical treatments, innovative therapies, and comprehensive aftercare programs. By constantly striving for medical excellence and employing experienced healthcare professionals, Mediclin AG aims to deliver optimal outcomes for patients. This company's commitment to delivering superior healthcare services has made it a trusted and reliable choice for individuals seeking top-notch medical care in Germany.

The Mediclin AG is a company in the healthcare sector that offers various services. The company's headquarters is located in Offenburg and it has clinics, rehabilitation facilities, and nursing homes throughout Germany. The company's divisions include acute hospitals, rehabilitation, post-acute medicine, nursing, and outpatient care. Acute hospitals treat patients with acute illnesses and injuries. The rehabilitation and post-acute medicine departments specialize in helping patients recover after accidents or surgeries. The nursing departments are responsible for caring for older or dependent people. The outpatient services offer various medical services that are provided outside of a hospital setting. Among the products offered by the company are check-up programs in which patients are examined for their health condition. In addition, the company also offers various weight reduction and personal development programs. Additionally, the company offers a variety of therapy services such as physiotherapy, occupational therapy, and speech therapy. The goal of Mediclin AG is to be a holistic healthcare provider that helps people stay healthy and fit on all levels. This means that the company not only offers medical services, but also is active on a psychological and social level. Another business field of the company is research and development. Mediclin AG is involved in various research projects aimed at improving medical care. The company works closely with universities and other research institutes to develop new and innovative methods and technologies. Mediclin AG is a listed company and is listed on the Frankfurt Stock Exchange. The company has a solid financial structure and is able to invest in growth and innovation to increase its competitiveness. Overall, Mediclin AG offers a variety of medical services and products to help people lead healthier lives on many levels. The company follows a comprehensive strategy that ranges from research and development to patient care and is continuously focused on innovation and renewal. Mediclin AG strives to be a reliable and trustworthy partner to its customers in their search for health and well-being.

API Docs Get API Key

Fair ValuePRO

3.48 EUR

Over-/UndervaluationPRO

13.0% undervalued

Expected Return

23.21 %

Sector

Health

Industry

Health Care Facilities

Number of shares

47,500,000

Employees

7,558

Revenue per Employee

101,227.27 EUR

Revenue growth Ø5 years

2.66 %

EBIT growth Ø5 years

231.23 %

Net Income growth Ø5 years

—

Website mediclin.de

Country

Germany 🇩🇪

Currency

EUR

Initial public offering

Dec 4, 2000

ISIN

DE0006595101

Cusip

D5315Z107

Sedol

4755094

Market capitalization

173.85 M EURMicro Cap

52-Week Range

3.52–3.88EUR

Mediclin Directors Dealings

Quality Investing

Details

4 / 10

Sales growth (10Y) > 5%

Revenue growth (3Y) > 5 %

EBIT growth (10Y) > 5%

EBIT growth (3Y) > 5 %

Net debt < 4x EBIT

Profitable since 10Y+

EBIT Drawdown (10Y) < 50%

Return on Equity (ROE) > 15%

ROCE > 15%

Return Expectation > 10%

PEG

7.73

P/E ratio

P/Ee 2025

4.96

P/Ee 2026

4.9

P/Ee 2027

4.83

P/S

0.23

P/Se

0.22

EV/EBIT

8.83

P/B Ratio

0.78

ROE (Return on Equity)

11.16 %

ROA (Return on Assets)

2.74 %

ROCE (Return on Capital Employed)

27 %

ROIC (Return on Invested Capital)

4.29 %

Gross Margin

83.13 %

EBIT Margin

7.85 %

Net Margin

3.25 %

EPS (Earnings Per Share)

0.52 EUR

Net Debt / EBIT

5.93

Debt/Equity

2.09

Dividend

0 EUR

Dividend yield

0 %

Est. Dividend Yield

5.56 %

Payout Ratio

27.23 %

Dividend growth Ø5Y

-4.36 %

Dividend payments per year

Dividend paid since

6 years+

Dividend not reduced since

0 years

Dividend increased since

0 years

Dividend withholding tax

26.38 %

Last updated Mar 12, 2026, 11:12 AM

Mediclin Peer Group

Mediclin Ticker

DÜSSELDORF · MED.DUFRANKFURT · MED.FHAMBURG · MED.HMLONDON · 0NDG.LMUNICH · MED.MUSIX · MEDCHF.SWXETRA · MED.DE

Mediclin FIGI

MED:GR · BBG000BDX715MED:GF · BBG000BDX7G9MED:GD · BBG000BDX831MED:GY · BBG000BDX8Q6MED:GS · BBG000BDX902MED:GM · BBG000BDX966MED:GB · BBG000BDX9Y5MED:GH · BBG000BDXBQ9MED5:EO · BBG000JL13V0MED5:XH · BBG000JL16P0MED5:XC · BBG000JL1750MED5:XF · BBG000JL17X9MED5:XE · BBG000JL18V9MED5:XJ · BBG000JL1965MED5:XL · BBG000JL19Y4MED5:XG · BBG000JL1BF0MED5:XO · BBG000JL1CC1MED5:XS · BBG000JL1DN7MED5:XA · BBG000JL1FV3MED5:E1 · BBG000JL1G50MED5:XT · BBG000JL1GF9MED5:XW · BBG000JL1GX9MED5:EU · BBG000JL1JR0MEDD:S1 · BBG001MBX6L5MEDD:IX · BBG002K13GR2MED5:XV · BBG00591L5S1MEDD:L3 · BBG006T9S5V9MEDD:B3 · BBG006TBKMH1MED:QT · BBG0077H9820MEDD:PO · BBG008H04M37MED:TH · BBG008NSVYJ6MED:GZ · BBG00FGWT480MED5:XM · BBG00J9VQ4B1MED5:XX · BBG00JN7HTZ7MEDCHF:SW · BBG00LVDY5K9MEDCHF:BW · BBG00LVDY5R20NDG:LN · BBG00NRVXLP1MEDD:L1 · BBG00Y9241K2MEDD:S4 · BBG00YJ83SC9MEDD:EB · BBG011CJNL81MEDD:I2 · BBG011CJNRN1MED:LA · BBG018H7JSW0MED:LU · BBG018J15WB0MED5CAD:EO · BBG01F7HV639MED5CAD:X2 · BBG01F7HV648MED5CAD:XH · BBG01F7HV666MED5CAD:XF · BBG01F7HV684MED5CAD:XE · BBG01F7HV6B0MED5CAD:XJ · BBG01F7HV6C9MED5CAD:XL · BBG01F7HV6D8MED5CAD:XG · BBG01F7HV6F6MED5CAD:XO · BBG01F7HV6G5MED5CAD:XA · BBG01F7HV6L9MED5CAD:E1 · BBG01F7HV6M8MED5CAD:XT · BBG01F7HV6N7MED5CAD:XW · BBG01F7HV6P5MED5CAD:XU · BBG01F7HV6Q4MED5CAD:XY · BBG01F7HV6R3MED5CAD:XV · BBG01F7HV6S2MED5CAD:XM · BBG01F7HV6T1MED5CAD:XQ · BBG01F7HV6V8MED5CAD:XX · BBG01F7HV6W7MED5CAD:XZ · BBG01F7HV6X6MED5CAD:X1 · BBG01F7HV6Z4MED5CAD:EU · BBG01F7HV719MED5USD:EO · BBG01F7HY2G1MED5USD:X2 · BBG01F7HY2H0MED5USD:XH · BBG01F7HY2K6MED5USD:XF · BBG01F7HY2M4MED5USD:XE · BBG01F7HY2P1MED5USD:XJ · BBG01F7HY2Q0MED5USD:XL · BBG01F7HY2R9MED5USD:XG · BBG01F7HY2S8MED5USD:XO · BBG01F7HY2T7MED5USD:XA · BBG01F7HY2Y1MED5USD:E1 · BBG01F7HY2Z0MED5USD:XT · BBG01F7HY306MED5USD:XW · BBG01F7HY315MED5USD:XU · BBG01F7HY324MED5USD:XY · BBG01F7HY333MED5USD:XV · BBG01F7HY342MED5USD:XM · BBG01F7HY351MED5USD:XQ · BBG01F7HY360MED5USD:XX · BBG01F7HY379MED5USD:XZ · BBG01F7HY388MED5USD:X1 · BBG01F7HY3B4MED5USD:EU · BBG01F7HY3D2MEDD:QX · BBG01JWT79P4MEDD:QE · BBG01JWT81P0

All fundamentals about Mediclin

Our stock analysis for Mediclin Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Mediclin Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Mediclin Directors Dealings→

Mediclin Stocks→

Mediclin Market capitalization→

Mediclin Debt→

Mediclin Liabilities→

Mediclin Equity→